DK3049117T3 - Ultralydsmedieret afgivelse af lægemidler - Google Patents

Ultralydsmedieret afgivelse af lægemidler Download PDF

Info

Publication number
DK3049117T3
DK3049117T3 DK14847119.6T DK14847119T DK3049117T3 DK 3049117 T3 DK3049117 T3 DK 3049117T3 DK 14847119 T DK14847119 T DK 14847119T DK 3049117 T3 DK3049117 T3 DK 3049117T3
Authority
DK
Denmark
Prior art keywords
ultrasound
drugs
mediated delivery
mediated
delivery
Prior art date
Application number
DK14847119.6T
Other languages
English (en)
Inventor
Andrew John Healey
Per Christian Sontum
Svein Kvåle
Original Assignee
Exact Therapeutics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exact Therapeutics As filed Critical Exact Therapeutics As
Application granted granted Critical
Publication of DK3049117T3 publication Critical patent/DK3049117T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0078—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion microemulsion, nanoemulsion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK14847119.6T 2013-09-27 2014-09-26 Ultralydsmedieret afgivelse af lægemidler DK3049117T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20131293 2013-09-27
PCT/NO2014/050177 WO2015047103A1 (en) 2013-09-27 2014-09-26 Ultrasound mediated delivery of drugs

Publications (1)

Publication Number Publication Date
DK3049117T3 true DK3049117T3 (da) 2022-10-31

Family

ID=52744068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14847119.6T DK3049117T3 (da) 2013-09-27 2014-09-26 Ultralydsmedieret afgivelse af lægemidler

Country Status (15)

Country Link
US (7) US20160243234A1 (da)
EP (2) EP3049117B1 (da)
JP (2) JP6876436B2 (da)
CN (1) CN105658243B (da)
DK (1) DK3049117T3 (da)
ES (2) ES2951663T3 (da)
HR (1) HRP20221118T1 (da)
HU (1) HUE060034T2 (da)
LT (1) LT3049117T (da)
PL (1) PL3049117T3 (da)
PT (1) PT3049117T (da)
RS (1) RS63646B1 (da)
SI (1) SI3049117T1 (da)
SM (1) SMT202200398T1 (da)
WO (1) WO2015047103A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3049117T1 (sl) 2013-09-27 2022-11-30 Exact Therapeutics As Dostava zdravil, posredovana z ultrazvokom
JP6657225B2 (ja) 2014-12-19 2020-03-04 ユニヴェルシテ ピエール エ マリー キュリー（パリ シス）Ｕｎｉｖｅｒｓｉｔｅ Ｐｉｅｒｒｅ Ｅｔ Ｍａｒｉｅ Ｃｕｒｉｅ （Ｐａｒｉｓ Ｖｉ） 脳の治療のための埋め込み型超音波発生治療デバイス、そのようなデバイスを備える装置、及びそのようなデバイスを実装する方法
US20210106849A1 (en) * 2015-11-11 2021-04-15 NaviFUS Co. Ltd. Method and Kit for Treating Brain Tumor by using an Ultrasound System
JP6783319B2 (ja) 2016-03-11 2020-11-11 ソルボンヌ・ユニヴェルシテＳｏｒｂｏｎｎｅ Ｕｎｉｖｅｒｓｉｔｅ 脊髄の治療および／または脊髄神経の治療のための埋め込み型超音波発生治療デバイス、該デバイスを備える装置、および方法
US10981021B2 (en) * 2016-03-11 2021-04-20 Carthera Method for transiently disrupting a region of the blood-brain barrier of a human
CA3017916C (en) 2016-03-11 2023-11-07 Sorbonne Universite External ultrasound generating treating device for spinal cord and spinal nerves treatment, apparatus comprising such device and method implementing such device
US20200155679A1 (en) * 2017-05-29 2020-05-21 Bionaut Labs Ltd. Ultrasound resonance triggering of payload release from miniaturized devices
CN111032157B (zh) * 2017-06-29 2023-04-21 医视特有限公司 基于模拟的药物治疗计划
CN111587140A (zh) * 2018-01-02 2020-08-25 弗洛设计声能学公司 用于声驻波方法中的颗粒
WO2020061097A1 (en) * 2018-09-18 2020-03-26 The Johns Hopkins University Neuromodulation based nerve identification
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
US20220378692A1 (en) * 2019-10-25 2022-12-01 Exact Therapeutics As Treatment of pancreatic cancer
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
GB2605422B (en) * 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2605996B (en) * 2021-04-21 2024-09-25 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
WO2024050075A2 (en) * 2022-09-01 2024-03-07 Microvascular Therapeutics, Llc Methods and compositions for treatment of vascular obstruction
NO20221061A1 (en) * 2022-10-05 2024-04-08 Exact Therapeutics As Act enhanced ablation therapy
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356490A (en) 1992-04-01 1994-10-18 Henkel Corporation Composition and process for treating metal
US5335168A (en) 1993-01-13 1994-08-02 Compaq Computer Corporation Computer system with power-down mode for monitor
EP0727225A3 (en) 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasonic imaging
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
WO1998001297A1 (en) 1996-07-09 1998-01-15 Panex Corporation Quartz construction
JP2001502349A (ja) * 1996-10-21 2001-02-20 ニユコメド・イメージング・アクシエセルカペト 造影剤におけるまたはこれに関する改良
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
JP4772958B2 (ja) * 1998-02-09 2011-09-14 ブラッコ・リサーチ・ソシエテ・アノニム 生物学的に活性な媒質の標的に向けた送達
US6340976B1 (en) * 1998-04-15 2002-01-22 Mitsubishi Denki Kabushiki Kaisha Multivision system, color calibration method and display
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
JP2005168312A (ja) * 2003-12-08 2005-06-30 Mebiopharm Co Ltd 遺伝子類導入方法
WO2005063306A1 (en) * 2003-12-22 2005-07-14 Bracco Research Sa Assembly of gas-filled microvesicle with active component for contrast imaging
HUE024999T2 (en) 2004-08-26 2016-02-29 Engeneic Molecular Delivery Pty Ltd Introducing functional nucleic acids into mammalian cells with bacterial intact minicells
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
US10219815B2 (en) 2005-09-22 2019-03-05 The Regents Of The University Of Michigan Histotripsy for thrombolysis
JP2007197403A (ja) 2006-01-30 2007-08-09 Hitachi Ltd 薬物キャリアー及び超音波装置
JP5342102B2 (ja) 2006-07-04 2013-11-13 昭和電工株式会社 エマルション組成物
US20100298709A1 (en) 2009-04-17 2010-11-25 Visualsonics Inc. Method for nonlinear imaging of ultrasound contrast agents at high frequencies
EP2468191B1 (en) 2010-12-22 2019-01-30 Samsung Medison Co., Ltd. Ultrasound diagnosis apparatus for providing map of interest index
WO2012125172A1 (en) 2011-03-15 2012-09-20 Kona Medical, Inc. Energetic modulation of nerves
SI3049117T1 (sl) 2013-09-27 2022-11-30 Exact Therapeutics As Dostava zdravil, posredovana z ultrazvokom
US20210106849A1 (en) 2015-11-11 2021-04-15 NaviFUS Co. Ltd. Method and Kit for Treating Brain Tumor by using an Ultrasound System
US20200405258A1 (en) 2016-07-15 2020-12-31 The University Of North Carolina At Chapel Hill Methods and systems for using phase change nanodroplets to enhance sonothrombolysis
CA3049278A1 (en) 2017-01-05 2018-07-12 Warren Lee Apparatus, method, and use for ultrasound mediated microbubble delivery of pharmaceutical compositions
WO2019094802A1 (en) 2017-11-09 2019-05-16 Montefiore Medical Center Low energy immune priming for treating cancer and metastasis
CN108815725A (zh) 2018-04-04 2018-11-16 重庆融海超声医学工程研究中心有限公司 治疗剂量规划方法及系统
GB201819853D0 (en) 2018-12-05 2019-01-23 Innovation Ulster Ltd Therapy
KR20210126094A (ko) 2019-02-12 2021-10-19 더 보드 오브 트러스티즈 오프 더 리랜드 스탠포드 쥬니어 유니버시티 고강도 집속 초음파 시스템 및 방법
US11730452B2 (en) 2019-04-09 2023-08-22 Insightec Ltd. Systems and methods for regulating microbubbles in ultrasound procedures
KR102379296B1 (ko) 2019-09-02 2022-03-29 (주)아이엠지티 면역 마이크로버블 복합체 및 이의 이용
US20220378692A1 (en) 2019-10-25 2022-12-01 Exact Therapeutics As Treatment of pancreatic cancer
US11786760B2 (en) 2019-12-10 2023-10-17 GE Precision Healthcare LLC Multi-beam neuromodulation techniques
US11123046B1 (en) 2020-05-05 2021-09-21 Techsomed Medical Technologies Ltd. Monitoring thermal ablation using registration of B-mode ultrasound images
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
EP4222716A1 (en) 2020-09-29 2023-08-09 Koninklijke Philips N.V. Rendering of b-mode images based on tissue differentiation
GB2605422B (en) 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2605996B (en) 2021-04-21 2024-09-25 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents

Also Published As

Publication number Publication date
US20160243234A1 (en) 2016-08-25
EP4005604B8 (en) 2023-07-19
SMT202200398T1 (it) 2022-11-18
ES2951663T3 (es) 2023-10-24
JP7042862B2 (ja) 2022-03-28
EP4005604B1 (en) 2023-06-07
JP2020114846A (ja) 2020-07-30
US12343396B2 (en) 2025-07-01
US20260027211A1 (en) 2026-01-29
RS63646B1 (sr) 2022-11-30
EP3049117A1 (en) 2016-08-03
LT3049117T (lt) 2022-10-10
EP4005604A1 (en) 2022-06-01
US20230233681A1 (en) 2023-07-27
US20230241216A1 (en) 2023-08-03
EP3049117B1 (en) 2022-07-27
CN105658243B (zh) 2019-11-08
US20210299256A1 (en) 2021-09-30
US20230218759A1 (en) 2023-07-13
HRP20221118T1 (hr) 2022-12-23
WO2015047103A1 (en) 2015-04-02
JP2016532718A (ja) 2016-10-20
ES2927884T3 (es) 2022-11-11
US12377146B2 (en) 2025-08-05
EP4005604C0 (en) 2023-06-07
HUE060034T2 (hu) 2023-01-28
US20230218760A1 (en) 2023-07-13
US12478676B2 (en) 2025-11-25
PL3049117T3 (pl) 2022-11-07
JP6876436B2 (ja) 2021-05-26
EP3049117A4 (en) 2017-03-29
CN105658243A (zh) 2016-06-08
PT3049117T (pt) 2022-10-19
SI3049117T1 (sl) 2022-11-30

Similar Documents

Publication Publication Date Title
DK3049117T3 (da) Ultralydsmedieret afgivelse af lægemidler
BR112016009485A2 (pt) Inalador de medicamento
DK2968880T3 (da) Lægemiddelafgivelsesindretninger med lægemiddelpermeabel komponent
DK2961388T3 (da) Kombinationer af lægemidler
DK3669913T3 (da) Anordning til indgivelse af lægemidler
IL239527A0 (en) Medicament delivery device
EP3750590C0 (en) THRESHOLD RELEASE ADMINISTRATION CAPSULE
DK3922241T3 (da) Fjernladning af svært vandopløselige lægemidler i liposomer
DK3062849T3 (da) Medikamentadministrationsanordning
DK3639872T3 (da) Lægemiddeladministrationsanordning
DK3038674T3 (da) Medikamentafgivelsesindretning
DK2983721T4 (da) Terapeutiske indgivelsesvesikler
HRP20180684T1 (hr) Kombinacija lijekova
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3023100T3 (da) Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3024519T3 (da) Destruktion af hypodermiske kanyler
UA29750S (uk) Інгалятор
PT2968368T (pt) Administração craniana de substâncias farmacêuticas
IL262252B (en) Therapeutic compositions and methods involving mrna transfection
LT3035885T (lt) Inhaliatorius
DK3590499T3 (da) Inhalerbare lægemidler
DE112014004954T8 (de) Abgabesystem
DK3035886T3 (da) Inhalator
DK3043845T3 (da) Lægemiddelfremføringsanordning